CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
批准号:
2091959
负责人:
MICHAEL B LILLY
金额:
$10.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1997-02-28
关键词:
antisense nucleic acid apoptosis biological signal transduction colony stimulating factor cytokine gene expression hematopoietic growth factor myelogenous leukemia neoplasm /cancer immunology phenotype plasmids polymerase chain reaction recombinant proteins tissue /cell culture transfection western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from applicant's abstract)This application seeks
to characterize critical steps in the proliferative signalling pathways
activated by GM-CSF in related cytokines in primitive myeloid cells. At
least some cases of myeloid leukemia likely result from over activity
of such signal pathways. Identification of critical or unique steps in
such cascades may allow development of pharmacologic interventions to
specifically disrupt these pathways. The specific hypothesis of this
application is that expression of the pim-1 gene project, a 33 kd
serine/threonine kinase, is necessary for effective proliferative
signalling through GM-CSF and related receptors. The applicant further
hypothesizes that pim-1 expression serves as a specific indicator of
activation of such pathways. The hypothesis will be investigated by
constructing cell systems which allow for the over expression or blockade
of pim-1 activity. Factor-dependent myeloid cell lines will be
transfected with plasmid constructs or retroviral constructs to allow
autonomous expression of the pim-1 gene product.These lines will then
be examined for factor- independent growth, impaired differentiation,
inhibition of apoptosis and homotypic aggregation. Similar cell lines
will be created utilizing plasmids containing antisense pim-1 constructs
to inhibit activity of the endogenous pim-1 gene. These cells will be
studied for the responsiveness to GM-CSF and related cytokines and their
propensity to differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
-
批准号:8723134
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
-
批准号:8512436
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:9242567
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:8831452
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:7391006
-
项目类别:
-
资助金额:$3.09万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:6783914
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:6892356
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
-
批准号:2091960
-
项目类别:
-
资助金额:$9.47万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188842
-
项目类别:
-
资助金额:$4.21万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
-
批准号:2091961
-
项目类别:
-
资助金额:$10.51万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188844
-
项目类别:
-
资助金额:$8.8万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALLING IN MYELOID LEUKEMIAS
-
批准号:3509555
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188843
-
项目类别:
-
资助金额:$12.65万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188839
-
项目类别:
-
资助金额:$14.11万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177712
-
项目类别:
-
资助金额:$10.89万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177711
-
项目类别:
-
资助金额:$10.13万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177710
-
项目类别:
-
资助金额:$10.39万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
Murine model of chronic prostatitis
-
批准号:7547700
-
项目类别:
-
资助金额:$1.56万
-
财政年份:--
-
负责人:MICHAEL B LILLY
-
依托单位:
A Phase 1b Trial of Oligomeric Procyanidin Complex in Combination with Metformin for Reduced AGE Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
-
批准号:9419085
-
项目类别:
-
资助金额:$7.45万
-
财政年份:--
-
负责人:MICHAEL B LILLY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: